Sex hormones, through their receptors, such as the androgen receptor (AR) and estrogen receptors (ERα and ERβ), play crucial roles in the development, progression, and treatment resistance of hormone-responsive cancers like prostate, breast, ovarian, and endometrial cancers. The gene discussed is ESR1; the disease is endometrial cancer.